Equity-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Equity compensation expense is included in operating expenses and in selling, general and administrative expenses in the accompanying consolidated statements of comprehensive income (loss) as follows:

	For the Year Ended December 31,
	2021		2020		2019
	(In thousands)
Equity compensation expense included in operating expenses	$	9,578	$	522	$	4,076
Equity compensation expense included in selling, general and administrative expenses		30,144		6,945		7,030
Total equity compensation expense	$	39,722	$	7,467	$	11,106

Schedule of Time-Vesting and Performance Vesting Restricted Share Awards

The activity related to the Company’s time-vesting and performance-vesting restricted awards during the year ended December 31, 2021 was as follows:

						Performance-Vesting Restricted Awards
	Time-Vesting Restricted Awards					Bonus Performance Restricted Awards					Long-Term Incentive Performance Restricted Awards
	Shares/Units			Weighted Average Grant Date Fair Value per Award		Shares/Units			Weighted Average Grant Date Fair Value per Award		Shares/Units			Weighted Average Grant Date Fair Value per Award
Outstanding at December 31, 2020		1,692,579		$	14.18		23,298		$	26.16		1,467,636		$	23.38
Granted		243,573		$	53.14		132,251		$	51.64		232,954		$	51.33
Vested		(858,090	)	$	15.03		(22,569	)	$	26.16		(7,747	)	$	14.66
Forfeited		(140,042	)	$	24.73		(21,725	)	$	50.07		(702,840	)	$	20.75
Outstanding at December 31, 2021		938,020		$	21.94		111,255		$	51.78		990,003		$	31.90

Schedule of Activity Related to Stock Option Awards

The total intrinsic value of stock options exercised during the years ended December 31, 2021, 2020 and 2019 was approximately $9.5 million, $1.3 million and $2.4 million, respectively. The activity related to the Company’s stock option awards during the year ended December 31, 2021 was as follows:

	Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)		Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2020		679,988		$	21.51
Granted		177,688		$	51.52
Forfeited		(76,036	)	$	37.61
Expired		(3,639	)	$	20.01
Exercised		(289,567	)	$	20.40
Outstanding at December 31, 2021		488,434		$	30.59		7.08	$	16,739
Exercisable at December 31, 2021		227,462		$	21.61		5.41	$	9,838

Schedule of Stock Options Valuation Assumptions

The weighted average grant date fair value of stock options granted during the year ended December 31, 2021 was $29.17. Key weighted-average assumptions utilized in the Black-Scholes Option Pricing Model for stock options granted during the year ended December 31, 2021 were:

Risk-free interest rate	1.10	%
Expected volatility	61.22	%
Expected dividend yield	0.00	%
Expected life (years) ⁽^a⁾	6.13

(a)	The expected life was estimated using the simplified method, as the Company does not have sufficient historical exercise data due to the limited period of time its common stock has been publicly traded.